Dittmar J, Teplensky M, Evangelopoulos M, Qin L, Zhang B, Mirkin C
ACS Nano. 2023; 17(18):17996-18007.
PMID: 37713675
PMC: 10801821.
DOI: 10.1021/acsnano.3c04333.
Sun R, Liu M, Lu J, Chu B, Yang Y, Song B
Nat Commun. 2022; 13(1):5127.
PMID: 36050316
PMC: 9433534.
DOI: 10.1038/s41467-022-32837-5.
Kaewduangduen W, Visitchanakun P, Saisorn W, Phawadee A, Manonitnantawat C, Chutimaskul C
Int J Mol Sci. 2022; 23(3).
PMID: 35163830
PMC: 8836862.
DOI: 10.3390/ijms23031907.
Visitchanakun P, Kaewduangduen W, Chareonsappakit A, Susantitaphong P, Pisitkun P, Ritprajak P
Int J Mol Sci. 2021; 22(21).
PMID: 34768881
PMC: 8583992.
DOI: 10.3390/ijms222111450.
Ahn H, Carrington C, Hu Y, Liu H, Ng C, Nam H
Sci Rep. 2021; 11(1):9733.
PMID: 33958660
PMC: 8102550.
DOI: 10.1038/s41598-021-89124-4.
Bacteria and Host Interplay in Septic Arthritis and Sepsis.
Jin T, Mohammad M, Pullerits R, Ali A
Pathogens. 2021; 10(2).
PMID: 33546401
PMC: 7913561.
DOI: 10.3390/pathogens10020158.
The Central Role and Possible Mechanisms of Bacterial DNAs in Sepsis Development.
Cheng Z, Abrams S, Austin J, Toh J, Wang S, Wang Z
Mediators Inflamm. 2020; 2020:7418342.
PMID: 32934605
PMC: 7479481.
DOI: 10.1155/2020/7418342.
Cooperation of Oligodeoxynucleotides and Synthetic Molecules as Enhanced Immune Modulators.
Nigar S, Shimosato T
Front Nutr. 2019; 6:140.
PMID: 31508424
PMC: 6718720.
DOI: 10.3389/fnut.2019.00140.
Vaccination with nanoparticles combined with micro-adjuvants protects against cancer.
Mohsen M, Heath M, Cabral-Miranda G, Lipp C, Zeltins A, Sande M
J Immunother Cancer. 2019; 7(1):114.
PMID: 31027511
PMC: 6485085.
DOI: 10.1186/s40425-019-0587-z.
Low-grade infections as a possible cause of arthrofibrosis after total knee arthroplasty.
Bruckner C, Straube E, Petersen I, Sachse S, Keller P, Layher F
Patient Saf Surg. 2019; 13:1.
PMID: 30647774
PMC: 6327456.
DOI: 10.1186/s13037-018-0181-1.
A safe and highly efficient tumor-targeted type I interferon immunotherapy depends on the tumor microenvironment.
Cauwels A, Van Lint S, Garcin G, Bultinck J, Paul F, Gerlo S
Oncoimmunology. 2018; 7(3):e1398876.
PMID: 29399401
PMC: 5790344.
DOI: 10.1080/2162402X.2017.1398876.
Adjuvant-Loaded Spiky Gold Nanoparticles for Activation of Innate Immune Cells.
Nam J, Son S, Moon J
Cell Mol Bioeng. 2017; 10(5):341-355.
PMID: 29270238
PMC: 5734115.
DOI: 10.1007/s12195-017-0505-8.
Use of nanoparticles to deliver immunomodulatory oligonucleotides.
Klinman D, Sato T, Shimosato T
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2015; 8(4):631-7.
PMID: 26663867
PMC: 4903938.
DOI: 10.1002/wnan.1382.
Vaccine Potentiation by Combination Adjuvants.
Levast B, Awate S, Babiuk L, Mutwiri G, Gerdts V, van Drunen Littel-van den Hurk S
Vaccines (Basel). 2015; 2(2):297-322.
PMID: 26344621
PMC: 4494260.
DOI: 10.3390/vaccines2020297.
Anti-Inflammatory Effect of Apigenin on LPS-Induced Pro-Inflammatory Mediators and AP-1 Factors in Human Lung Epithelial Cells.
Patil R, Babu R, Kumar M, Kiran Kumar K, Hegde S, Nagesh R
Inflammation. 2015; 39(1):138-147.
PMID: 26276128
DOI: 10.1007/s10753-015-0232-z.
A novel role of kukoamine B: Inhibition of the inflammatory response in the livers of lipopolysaccharide-induced septic mice via its unique property of combining with lipopolysaccharide.
Qin W, Wang X, Shen W, Sun B
Exp Ther Med. 2015; 9(3):725-732.
PMID: 25667619
PMC: 4316986.
DOI: 10.3892/etm.2015.2188.
Adjuvant-carrying synthetic vaccine particles augment the immune response to encapsulated antigen and exhibit strong local immune activation without inducing systemic cytokine release.
Ilyinskii P, Roy C, ONeil C, Browning E, Pittet L, Altreuter D
Vaccine. 2014; 32(24):2882-95.
PMID: 24593999
PMC: 4059049.
DOI: 10.1016/j.vaccine.2014.02.027.
A monoclonal antibody against the human SUMO-1 protein obtained by immunization with recombinant protein and CpG-DNA-liposome complex.
Kim D, Lee J, Song D, Kwon S, Lee Y, Pan C
Monoclon Antib Immunodiagn Immunother. 2013; 32(5):354-61.
PMID: 24111868
PMC: 3798235.
DOI: 10.1089/mab.2013.0040.
DNA-based adaptive immunity protect host from infection-associated periodontal bone resorption via recognition of Porphyromonas gingivalis virulence component.
Han X, LaRosa K, Kawai T, Taubman M
Vaccine. 2013; 32(2):297-303.
PMID: 24051159
PMC: 3872268.
DOI: 10.1016/j.vaccine.2013.09.004.
Synthetic oligodeoxynucleotides containing suppressive TTAGGG motifs inhibit AIM2 inflammasome activation.
Kaminski J, Schattgen S, Tzeng T, Bode C, Klinman D, Fitzgerald K
J Immunol. 2013; 191(7):3876-83.
PMID: 23986531
PMC: 3878640.
DOI: 10.4049/jimmunol.1300530.
